simendan has been researched along with Injury, Ischemia-Reperfusion in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, HT; Chen, CH; Chen, YL; Chiang, JY; Sung, PH; Yang, CC; Yip, HK | 1 |
| Güven, BB; Özkan, S; Suakıtıcı, S; Tanoglu, A | 1 |
| Beiras-Fernandez, A; Bogert, NV; Brunner, SN; Juengel, E; Kornberger, A; Moritz, A; Schnitzbauer, AA; Werner, I | 1 |
| Bleilevens, C; Bruells, C; Hein, M; Roehl, AB; Rossaint, R; Zoremba, N | 1 |
| Albayrak, A; Atamanalp, SS; Bayir, Y; Cadirci, E; Demirci, E; Halici, Z; Karakus, E; Odaci, E; Polat, B; Yayla, M | 1 |
| Balla, Z; Fulop, A; Garbaisz, D; Harsanyi, L; Hegedus, V; Lotz, G; Onody, P; Rakonczay, Z; Rosero, O; Stangl, R; Szijarto, A; Turoczi, Z | 1 |
| Bellofatto, K; Farruggio, S; Grossini, E; Mary, DA; Mombello, C; Origlia, V; Pollesello, P; Sigaudo, L; Vacca, G; Valente, G | 1 |
| Abdel-Gaber, SA; Abdelrahman, AM; Amin, EF; Ibrahim, MA; Ibrahim, SA; Mohammed, RK | 1 |
| Ge, S; Guo, Z; Liu, H; Shi, Y; Zhang, C | 1 |
| Alkan, M; Arslan, M; Comu, FM; Kip, G; Kiraz, HA; Ozer, A; Sivgin, V | 1 |
| Galatou, E; Lazou, A; Makridou, Z; Markou, T | 1 |
| Bellomo, G; Caimmi, P; Grossini, E; Mary, D; Molinari, C; Pollesello, P; Vacca, G; Valente, G | 1 |
| Aksun, M; Bahriye Lafci, B; Gurbuz, A; Ortac, R; Ozbek, C; Tulukoglu, E; Yakut, N; Yasa, H | 1 |
| Emrecan, B; Ergunes, K; Gurbuz, A; Karahan, N; Ortac, R; Ozbek, C; Yakut, N; Yasa, H | 1 |
14 other study(ies) available for simendan and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat.
Topics: Aminobutyrates; Animals; Apoptosis; Biphenyl Compounds; Cardio-Renal Syndrome; Cardiovascular Agents; Drug Combinations; Fibrosis; Humans; Inflammation; Kidney; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Simendan; Stroke Volume; Valsartan; Ventricular Function, Left | 2022 |
A combination of levosimendan and N-Acetylcysteine shows significant favorable efficacy on experimental liver ischemia/reperfusion injury.
Topics: Acetylcysteine; Animals; Liver; Liver Diseases; Oxidative Stress; Protective Agents; Rats; Reperfusion Injury; Simendan | 2021 |
Levosimendan protects human hepatocytes from ischemia-reperfusion injury.
Topics: Apoptosis; bcl-2-Associated X Protein; Cells, Cultured; Hepatocytes; Humans; Hydrazones; Pyridazines; Reperfusion Injury; Simendan | 2017 |
Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model.
Topics: Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Hydrazones; Infarction, Middle Cerebral Artery; Male; Pyridazines; Rats; Rats, Wistar; Reperfusion Injury; Simendan; Stroke; Tumor Necrosis Factor-alpha | 2013 |
The effect of levosimendan in rat mesenteric ischemia/reperfusion injury.
Topics: Animals; Hydrazones; Interleukin-1beta; Interleukin-6; Intestines; NF-kappa B; Pyridazines; Rats; Reperfusion Injury; RNA, Messenger; Simendan; Tumor Necrosis Factor-alpha | 2013 |
Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blotting, Western; Cardiotonic Agents; DNA Damage; HSP72 Heat-Shock Proteins; Hydrazones; Immunohistochemistry; Liver; Male; Microcirculation; Mitochondria; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Pyridazines; Rats; Rats, Wistar; Reperfusion Injury; Simendan; Time Factors; Treatment Outcome | 2013 |
Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats.
Topics: Anesthesia; Animals; Apoptosis; bcl-2-Associated X Protein; Biopsy; Blood Flow Velocity; Caspase 3; Cell Survival; Decanoic Acids; Glutathione; Hydrazones; Hydroxy Acids; Liver; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphodiesterase Inhibitors; Portal Vein; Potassium Channels; Pyridazines; Rats; Reperfusion Injury; Simendan; Thiobarbituric Acid Reactive Substances | 2014 |
Molecular mechanisms contributing to the protective effect of levosimendan in liver ischemia-reperfusion injury.
Topics: Animals; Hydrazones; Liver; Male; Phosphodiesterase Inhibitors; Pyridazines; Rats; Rats, Wistar; Reperfusion Injury; Simendan | 2014 |
Influence of levosimendan postconditioning on apoptosis of rat lung cells in a model of ischemia-reperfusion injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 3; Decanoic Acids; Disease Models, Animal; Hydrazones; Hydroxy Acids; Lung; Lung Diseases; Male; Pyridazines; Rats; Reperfusion Injury; Simendan | 2015 |
Effect of levosimendan on erythrocyte deformability during myocardial ischaemia-reperfusion injury.
Topics: Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Disease Models, Animal; Erythrocyte Deformability; Hydrazones; Male; Myocardial Reperfusion Injury; Pyridazines; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Simendan; Streptozocin | 2015 |
Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes.
Topics: Animals; Cardiotonic Agents; Cytoprotection; Hydrazones; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Oxygen; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridazines; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Simendan | 2011 |
Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Survival; Decanoic Acids; Glucose; Hydrazones; Hydroxy Acids; KATP Channels; Kidney; Mannitol; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Chloride; Procaine; Pyridazines; Reperfusion Injury; Simendan; Swine | 2012 |
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study.
Topics: Animals; Atrophy; Disease Models, Animal; Female; Hydrazones; Iloprost; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Protective Agents; Pyridazines; Rabbits; Reperfusion Injury; Simendan | 2008 |
Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model.
Topics: Animals; Disease Models, Animal; Extremities; Female; Hydrazones; Iloprost; Lung; Male; Malondialdehyde; Pyridazines; Rabbits; Reperfusion Injury; Simendan | 2008 |